194 related articles for article (PubMed ID: 10632109)
1. Atypical refsum disease with pipecolic acidemia and abnormal catalase distribution.
Baumgartner MR; Jansen GA; Verhoeven NM; Mooyer PA; Jakobs C; Roels F; Espeel M; Fourmaintraux A; Bellet H; Wanders RJ; Saudubray JM
Ann Neurol; 2000 Jan; 47(1):109-13. PubMed ID: 10632109
[TBL] [Abstract][Full Text] [Related]
2. Phytanoyl-coenzyme A hydroxylase deficiency -- the enzyme defect in Refsum's disease.
Jansen GA; Wanders RJ; Watkins PA; Mihalik SJ
N Engl J Med; 1997 Jul; 337(2):133-4. PubMed ID: 9221344
[No Abstract] [Full Text] [Related]
3. Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism.
Lloyd MD; Mukherji M; Kershaw NJ; Chien W; Wierzbicki AS; Schofield CJ
Adv Exp Med Biol; 2003; 544():303-4. PubMed ID: 14713244
[No Abstract] [Full Text] [Related]
4. Refsum disease is caused by mutations in the phytanoyl-CoA hydroxylase gene.
Jansen GA; Ofman R; Ferdinandusse S; Ijlst L; Muijsers AO; Skjeldal OH; Stokke O; Jakobs C; Besley GT; Wraith JE; Wanders RJ
Nat Genet; 1997 Oct; 17(2):190-3. PubMed ID: 9326940
[TBL] [Abstract][Full Text] [Related]
5. Disorders related to the metabolism of phytanic acid.
Stokke O; Skjeldal OH; Høie K
Scand J Clin Lab Invest Suppl; 1986; 184():3-10. PubMed ID: 2438746
[TBL] [Abstract][Full Text] [Related]
6. Identification of PAHX, a Refsum disease gene.
Mihalik SJ; Morrell JC; Kim D; Sacksteder KA; Watkins PA; Gould SJ
Nat Genet; 1997 Oct; 17(2):185-9. PubMed ID: 9326939
[TBL] [Abstract][Full Text] [Related]
7. Restoration of phytanic acid oxidation in Refsum disease fibroblasts from patients with mutations in the phytanoyl-CoA hydroxylase gene.
Chahal A; Khan M; Pai SG; Barbosa E; Singh I
FEBS Lett; 1998 Jun; 429(1):119-22. PubMed ID: 9657395
[TBL] [Abstract][Full Text] [Related]
8. Peroxisomal disorders affecting phytanic acid alpha-oxidation: a review.
Wierzbicki AS
Biochem Soc Trans; 2007 Nov; 35(Pt 5):881-6. PubMed ID: 17956237
[TBL] [Abstract][Full Text] [Related]
9. Further studies on the substrate spectrum of phytanoyl-CoA hydroxylase: implications for Refsum disease?
Foulon V; Asselberghs S; Geens W; Mannaerts GP; Casteels M; Van Veldhoven PP
J Lipid Res; 2003 Dec; 44(12):2349-55. PubMed ID: 12923223
[TBL] [Abstract][Full Text] [Related]
10. Molecular basis of Refsum disease: sequence variations in phytanoyl-CoA hydroxylase (PHYH) and the PTS2 receptor (PEX7).
Jansen GA; Waterham HR; Wanders RJ
Hum Mutat; 2004 Mar; 23(3):209-18. PubMed ID: 14974078
[TBL] [Abstract][Full Text] [Related]
11. Refsum disease: a defect in the alpha-oxidation of phytanic acid in peroxisomes.
Singh I; Pahan K; Singh AK; Barbosa E
J Lipid Res; 1993 Oct; 34(10):1755-64. PubMed ID: 7504046
[TBL] [Abstract][Full Text] [Related]
12. Peroxisomal functions in classical Refsum's disease: comparison with the infantile form of Refsum's disease.
Wanders RJ; Heymans HS; Schutgens RB; Poll-Thé BT; Saudubray JM; Tager JM; Schrakamp G; van den Bosch H
J Neurol Sci; 1988 Apr; 84(2-3):147-55. PubMed ID: 2454298
[TBL] [Abstract][Full Text] [Related]
13. Infantile Refsum's disease: a peroxisomal storage disorder?
Manson JI; Pollard AC; Poulos A; Carter RF
Clin Exp Neurol; 1985; 21():283-7. PubMed ID: 2436838
[TBL] [Abstract][Full Text] [Related]
14. Brain pyruvate and 2-oxoglutarate dehydrogenase complexes are mitochondrial targets of the CoA ester of the Refsum disease marker phytanic acid.
Bunik VI; Raddatz G; Wanders RJ; Reiser G
FEBS Lett; 2006 Jun; 580(14):3551-7. PubMed ID: 16737698
[TBL] [Abstract][Full Text] [Related]
15. Phytanic acid oxidation: normal activation and transport yet defective alpha-hydroxylation of phytanic acid in peroxisomes from Refsum disease and rhizomelic chondrodysplasia punctata.
Pahan K; Khan M; Singh I
J Lipid Res; 1996 May; 37(5):1137-43. PubMed ID: 8725164
[TBL] [Abstract][Full Text] [Related]
16. Refsum disease, peroxisomes and phytanic acid oxidation: a review.
Wanders RJ; Jansen GA; Skjeldal OH
J Neuropathol Exp Neurol; 2001 Nov; 60(11):1021-31. PubMed ID: 11706932
[TBL] [Abstract][Full Text] [Related]
17. Peroxisomes, Refsum's disease and the alpha- and omega-oxidation of phytanic acid.
Wanders RJ; Komen JC
Biochem Soc Trans; 2007 Nov; 35(Pt 5):865-9. PubMed ID: 17956234
[TBL] [Abstract][Full Text] [Related]
18. Identification of pristanal dehydrogenase activity in peroxisomes: conclusive evidence that the complete phytanic acid alpha-oxidation pathway is localized in peroxisomes.
Jansen GA; van den Brink DM; Ofman R; Draghici O; Dacremont G; Wanders RJ
Biochem Biophys Res Commun; 2001 May; 283(3):674-9. PubMed ID: 11341778
[TBL] [Abstract][Full Text] [Related]
19. Localization of Refsum disease with increased pipecolic acidaemia to chromosome 10p by homozygosity mapping and carrier testing in a single nuclear family.
Nadal N; Rolland MO; Tranchant C; Reutenauer L; Gyapay G; Warter JM; Mandel JL; Koenig M
Hum Mol Genet; 1995 Oct; 4(10):1963-6. PubMed ID: 8595422
[TBL] [Abstract][Full Text] [Related]
20. [Refsum's disease: evolution 35 years after diagnosis].
Marcaud V; Defontaines B; Jung P; Degos CF
Rev Neurol (Paris); 2002 Feb; 158(2):225-9. PubMed ID: 11965181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
